{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:19:08Z","timestamp":1778534348624,"version":"3.51.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/nrd2742","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T06:13:46Z","timestamp":1233296026000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2687,"title":["Knocking down barriers: advances in siRNA delivery"],"prefix":"10.1038","volume":"8","author":[{"given":"Kathryn A.","family":"Whitehead","sequence":"first","affiliation":[]},{"given":"Robert","family":"Langer","sequence":"additional","affiliation":[]},{"given":"Daniel G.","family":"Anderson","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnrd2742_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806\u2013811 (1998). The first study to describe the phenomenon of RNAi.","journal-title":"Nature"},{"key":"BFnrd2742_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494\u2013498 (2001). The first study to demonstrate that exogenous siRNA is capable of sequence-specific knockdown in mammalian cells.","journal-title":"Nature"},{"key":"BFnrd2742_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/418038a","volume":"418","author":"AP McCaffrey","year":"2002","unstructured":"McCaffrey, A. P. et al. Gene expression: RNA interference in adult mice. Nature 418, 38\u201339 (2002). Describes the first observation of sequence-specific gene silencing in mice using siRNA.","journal-title":"Nature"},{"key":"BFnrd2742_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"DV Morrissey","year":"2005","unstructured":"Morrissey, D. V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotech. 23, 1002\u20131007 (2005).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR5","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1073\/pnas.0710629105","volume":"105","author":"A Okumura","year":"2008","unstructured":"Okumura, A., Pitha, P. M. & Harty, R. N. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl Acad. Sci. USA 105, 3974\u20133979 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm1127","volume":"10","author":"A Ptasznik","year":"2004","unstructured":"Ptasznik, A., Nakata, Y., Kalota, A., Emerson, S. G. & Gewirtz, A. M. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1+ leukemia cells. Nature Med. 10, 1187\u20131189 (2004).","journal-title":"Nature Med."},{"key":"BFnrd2742_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jconrel.2008.03.008","volume":"129","author":"SH Kim","year":"2008","unstructured":"Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W. & Park, T. G. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control. Release 129, 107\u2013116 (2008).","journal-title":"J. Control. Release"},{"key":"BFnrd2742_CR8","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s11095-007-9460-8","volume":"24","author":"C-F Xia","year":"2007","unstructured":"Xia, C.-F., Zhang, Y., Zhang, Y., Boado, R. & Pardridge, W. Intravenous siRNA of brain cancer with receptor targeting and avidin\u2013biotin technology. Pharm. Res. 24, 2309\u20132316 (2007).","journal-title":"Pharm. Res."},{"key":"BFnrd2742_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/35053110","volume":"409","author":"E Bernstein","year":"2001","unstructured":"Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363\u2013366 (2001).","journal-title":"Nature"},{"key":"BFnrd2742_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm, D. et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441, 537\u2013541 (2006).","journal-title":"Nature"},{"key":"BFnrd2742_CR11","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.1073\/pnas.0405913101","volume":"101","author":"TA Rand","year":"2004","unstructured":"Rand, T. A., Ginalski, K., Grishin, N. V. & Wang, X. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc. Natl Acad. Sci. USA 101, 14385\u201314389 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2005.08.044","volume":"123","author":"C Matranga","year":"2005","unstructured":"Matranga, C., Tomari, Y., Shin, C., Bartel, D. P. & Zamore, P. D. Passenger-strand cleavage facilitates assembly of siRNA into ago2-containing RNAi enzyme complexes. Cell 123, 607\u2013620 (2005).","journal-title":"Cell"},{"key":"BFnrd2742_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2007.04.037","volume":"130","author":"SL Ameres","year":"2007","unstructured":"Ameres, S. L., Martinez, J. & Schroeder, R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130, 101\u2013112 (2007).","journal-title":"Cell"},{"key":"BFnrd2742_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cell.2005.10.020","volume":"123","author":"TA Rand","year":"2005","unstructured":"Rand, T. A., Petersen, S., Du, F. & Wang, X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123, 621\u2013629 (2005).","journal-title":"Cell"},{"key":"BFnrd2742_CR15","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutvagner","year":"2002","unstructured":"Hutvagner, G. & Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056\u20132060 (2002).","journal-title":"Science"},{"key":"BFnrd2742_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/nar\/gkj439","volume":"34","author":"DW Bartlett","year":"2006","unstructured":"Bartlett, D. W. & Davis, M. E. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 34, 322\u2013333 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd2742_CR17","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1073\/pnas.0805434105","volume":"105","author":"M Frank-Kamenetsky","year":"2008","unstructured":"Frank-Kamenetsky, M. et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl Acad. Sci. USA 105, 11915\u201311920 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nature Biotech. 26, 431\u2013442 (2008).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E Song","year":"2003","unstructured":"Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347\u2013351 (2003).","journal-title":"Nature Med."},{"key":"BFnrd2742_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1525-1438.2006.00384.x","volume":"16","author":"X-Y Niu","year":"2006","unstructured":"Niu, X.-Y., Peng, Z. L., Duan, W. Q., Wang, H. & Wang, P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int. J. Gynecol. Cancer 16, 743\u2013751 (2006).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"BFnrd2742_CR21","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1158\/1078-0432.CCR-06-0021","volume":"12","author":"J Halder","year":"2006","unstructured":"Halder, J. et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. 12, 4916\u20134924 (2006).","journal-title":"Clin. Cancer Res."},{"key":"BFnrd2742_CR22","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.1073\/pnas.0501753102","volume":"102","author":"F Takeshita","year":"2005","unstructured":"Takeshita, F. et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl Acad. Sci. USA 102, 12177\u201312182 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR23","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl Acad. Sci. USA 104, 17204\u201317209 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.coph.2008.04.005","volume":"8","author":"A de Fougerolles","year":"2008","unstructured":"de Fougerolles, A. & Novobrantseva, T. siRNA and the lung: research tool or therapeutic drug? Curr. Opin. Pharmacol. 8, 280\u2013285 (2008).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrd2742_CR25","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/jgm.1091","volume":"9","author":"T Inoue","year":"2007","unstructured":"Inoue, T. et al. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA. J. Gene Med. 9, 994\u20131001 (2007).","journal-title":"J. Gene Med."},{"key":"BFnrd2742_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.addr.2006.07.020","volume":"58","author":"E Fattal","year":"2006","unstructured":"Fattal, E. & Bochot, A. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv. Drug Deliv. Rev. 58, 1203\u20131223 (2006).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrd2742_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature04263","volume":"439","author":"D Palliser","year":"2006","unstructured":"Palliser, D. et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89\u201394 (2006).","journal-title":"Nature"},{"key":"BFnrd2742_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/hum.2006.17.751","volume":"17","author":"M Grzelinski","year":"2006","unstructured":"Grzelinski, M. et al. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17, 751\u2013766 (2006).","journal-title":"Hum. Gene Ther."},{"key":"BFnrd2742_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm1164","volume":"11","author":"V Bitko","year":"2005","unstructured":"Bitko, V., Musiyenko, A., Shulyayeva, O. & Barik, S. Inhibition of respiratory viruses by nasally administered siRNA. Nature Med. 11, 50\u201355 (2005).","journal-title":"Nature Med."},{"key":"BFnrd2742_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nbt1402","volume":"26","author":"A Akinc","year":"2008","unstructured":"Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nature Biotech. 26, 561\u2013569 (2008). Describes the combinatorial synthesis and  in vivo  delivery performance of a large library of lipid-like materials in multiple animal models and species.","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","volume":"77","author":"J DeVincenzo","year":"2008","unstructured":"DeVincenzo, J. et al. Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res. 77, 225\u2013231 (2008).","journal-title":"Antiviral Res."},{"key":"BFnrd2742_CR32","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1280","volume":"11","author":"B-J Li","year":"2005","unstructured":"Li, B.-J. et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature Med. 11, 944\u2013951 (2005).","journal-title":"Nature Med."},{"key":"BFnrd2742_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505\u2013515 (2008).","journal-title":"Mol. Pharm."},{"key":"BFnrd2742_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-642-75862-1_8","volume-title":"Targeted Drug Delivery","author":"GL Scherphof","year":"1991","unstructured":"Scherphof, G. L. in Targeted Drug Delivery (ed. Juliano, R. L.) 285\u2013313 (Springer, Berlin, 1991)."},{"key":"BFnrd2742_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.0305-1846.2003.00541.x","volume":"30","author":"J Z\u00e1mecn\u00edk","year":"2004","unstructured":"Z\u00e1mecn\u00edk, J., Vargov\u00e1, L., Homola, A., Kodet, R. & Sykov\u00e1, E. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol. Appl. Neurobiol. 30, 338\u2013350 (2004).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrd2742_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijpharm.2006.11.050","volume":"331","author":"S Oliveira","year":"2007","unstructured":"Oliveira, S., van Rooy, I., Kranenburg, O., Storm, G. & Schiffelers, R. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm. 331, 211\u2013214 (2007).","journal-title":"Int. J. Pharm."},{"key":"BFnrd2742_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ncb975","volume":"5","author":"GM Di Guglielmo","year":"2003","unstructured":"Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F. & Wrana, J. L. Distinct endocytic pathways regulate TGF-\u03b2 receptor signalling and turnover. Nature Cell Biol. 5, 410\u2013421 (2003).","journal-title":"Nature Cell Biol."},{"key":"BFnrd2742_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm1191","volume":"11","author":"V Hornung","year":"2005","unstructured":"Hornung, V. et al. Sequence-specific potent induction of IFN-\u03b1 by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nature Med 11, 263\u2013270 (2005). The TLR7 pathway is identified as an important contributor to nonspecific siRNA immune activation.","journal-title":"Nature Med"},{"key":"BFnrd2742_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nbt1081","volume":"23","author":"AD Judge","year":"2005","unstructured":"Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotech. 23, 457\u2013462 (2005).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymthe.2005.11.002","volume":"13","author":"AD Judge","year":"2006","unstructured":"Judge, A. D., Bola, G., Lee, A. C. H. & MacLachlan, I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13, 494\u2013505 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2742_CR41","unstructured":"Vornlocher, H.-P. et al. Nuclease-resistant double-stranded RNA for RNA interference. WO2005115481 (2005)."},{"key":"BFnrd2742_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1261\/rna.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson, A. L. et al. Position-specific chemical modification of siRNAs reduces \u201coff-target\u201d transcript silencing. RNA 12, 1197\u20131205 (2006).","journal-title":"RNA"},{"key":"BFnrd2742_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot, D., Manoharan, M., Koteliansky, V. & Sah, D. W. Y. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chem. Biol. 2, 711\u2013719 (2006).","journal-title":"Nature Chem. Biol."},{"key":"BFnrd2742_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-5793(03)01505-9","volume":"558","author":"A Muratovska","year":"2004","unstructured":"Muratovska, A. & Eccles, M. R. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558, 63\u201368 (2004).","journal-title":"FEBS Lett."},{"key":"BFnrd2742_CR45","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1021\/ja044941d","volume":"127","author":"M Oishi","year":"2005","unstructured":"Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N. & Kataoka, K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile \u03b2-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127, 1624\u20131625 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrd2742_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature03121","volume":"432","author":"J Soutschek","year":"2004","unstructured":"Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173\u2013178 (2004).","journal-title":"Nature"},{"key":"BFnrd2742_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nbt1339","volume":"25","author":"C Wolfrum","year":"2007","unstructured":"Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotech. 25, 1149\u20131157 (2007).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.108.786822","volume":"118","author":"E Merki","year":"2008","unstructured":"Merki, E. et al. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice. Circulation 118, 743\u2013753 (2008).","journal-title":"Circulation"},{"key":"BFnrd2742_CR49","unstructured":"Isis Pharmaceuticals. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen. Isis Pharmaceuticals web site [online], (2008)."},{"key":"BFnrd2742_CR50","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1073\/pnas.0435906100","volume":"100","author":"VP Torchilin","year":"2003","unstructured":"Torchilin, V. P. et al. Cell transfection in vitro and in vivo with nontoxic TAT peptide\u2013liposome\u2013DNA complexes. Proc. Natl Acad. Sci. USA 100, 1972\u20131977 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jconrel.2008.06.004","volume":"130","author":"DT Auguste","year":"2008","unstructured":"Auguste, D. T. et al. Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. J. Control. Release 130, 266\u2013274 (2008).","journal-title":"J. Control. Release"},{"key":"BFnrd2742_CR52","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1016\/j.biomaterials.2007.05.025","volume":"28","author":"M-S Martina","year":"2007","unstructured":"Martina, M.-S. et al. The in vitro kinetics of the interactions between PEG-ylated magnetic-fluid-loaded liposomes and macrophages. Biomaterials 28, 4143\u20134153 (2007).","journal-title":"Biomaterials"},{"key":"BFnrd2742_CR53","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/bc060129j","volume":"17","author":"S Mao","year":"2006","unstructured":"Mao, S. et al. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer\/siRNA polyplexes. Bioconjug. Chem. 17, 1209\u20131218 (2006).","journal-title":"Bioconjug. Chem."},{"key":"BFnrd2742_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jgm.634","volume":"7","author":"W Li","year":"2005","unstructured":"Li, W., Huang, Z., MacKay, J. A., Grube, S. & Szoka, F. C. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J. Gene Med. 7, 67\u201379 (2005).","journal-title":"J. Gene Med."},{"key":"BFnrd2742_CR55","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.bmcl.2003.12.074","volume":"14","author":"DA Braasch","year":"2004","unstructured":"Braasch, D. A. et al. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg. Med. Chem. Lett. 14, 1139\u20131143 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnrd2742_CR56","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/jcb.21689","volume":"104","author":"AA Bogdanov","year":"2008","unstructured":"Bogdanov, A. A. Merging molecular imaging and RNA interference: early experience in live animals. J. Cell Biochem. 104, 1113\u20131123 (2008).","journal-title":"J. Cell Biochem."},{"key":"BFnrd2742_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature04688","volume":"441","author":"TS Zimmermann","year":"2006","unstructured":"Zimmermann, T. S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111\u2013114 (2006). The first study to demonstrate sequence-specific RNAi in non-human primates.","journal-title":"Nature"},{"key":"BFnrd2742_CR58","doi-asserted-by":"publisher","first-page":"F605","DOI":"10.1152\/ajprenal.90268.2008","volume":"295","author":"H Yuan","year":"2008","unstructured":"Yuan, H. et al. Effects of cholesterol-tagged small interfering RNAs targeting 12\/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Am. J. Physiol. Renal Physiol. 295, F605\u2013F617 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrd2742_CR59","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/ki.1995.205","volume":"47","author":"J Rappaport","year":"1995","unstructured":"Rappaport, J. et al. Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int. 47, 1462\u20131469 (1995).","journal-title":"Kidney Int."},{"key":"BFnrd2742_CR60","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/sj.gt.3302777","volume":"13","author":"A Santel","year":"2006","unstructured":"Santel, A. et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther. 13, 1222\u20131234 (2006).","journal-title":"Gene Ther."},{"key":"BFnrd2742_CR61","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1124\/dmd.106.009555","volume":"34","author":"FM van de Water","year":"2006","unstructured":"van de Water, F. M. et al. Intravenousely administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab. Dispos. 34, 1393\u20131397 (2006).","journal-title":"Drug Metab. Dispos."},{"key":"BFnrd2742_CR62","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1158\/0008-5472.CAN-03-2682","volume":"64","author":"Y Takei","year":"2004","unstructured":"Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S. & Muramatsu, T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 64, 3365\u20133370 (2004).","journal-title":"Cancer Res."},{"key":"BFnrd2742_CR63","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"JO McNamara","year":"2006","unstructured":"McNamara, J. O. et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotech. 24, 1005\u20131015 (2006).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nbt1101","volume":"23","author":"E Song","year":"2005","unstructured":"Song, E. et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nature Biotech. 23, 709\u2013717 (2005).","journal-title":"Nature Biotech."},{"key":"BFnrd2742_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1126\/science.1149859","volume":"319","author":"D Peer","year":"2008","unstructured":"Peer, D., Park, E. J., Morishita, Y., Carman, C. V. & Shimaoka, M. Systemic leukocyte-directed siRNA delivery revealing Cyclin D1 as an anti-inflammatory target. Science 319, 627\u2013630 (2008).","journal-title":"Science"},{"key":"BFnrd2742_CR66","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/sj.gt.3302363","volume":"11","author":"J Barquinero","year":"2004","unstructured":"Barquinero, J., Eixarch, H. & Perez-Melgosa, M. Retroviral vectors: new applications for an old tool. Gene Ther. 11, S3\u2013S9 (2004).","journal-title":"Gene Ther."},{"key":"BFnrd2742_CR67","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jgm.1202","volume":"10","author":"RE Vandenbroucke","year":"2008","unstructured":"Vandenbroucke, R. E. et al. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(\u03b2-amino esters). J. Gene Med. 10, 783\u2013794 (2008).","journal-title":"J. Gene Med."},{"key":"BFnrd2742_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nature Rev. Drug Discov. 4, 145\u2013160 (2005).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd2742_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1201\/9780849387951.ch9","volume-title":"Antisense Drug Technology: Principles, Strategies and Applications","author":"I MacLachlan","year":"2007","unstructured":"MacLachlan, I. in Antisense Drug Technology: Principles, Strategies and Applications. 2nd edn Ch. 9 (ed. Crooke, S. T.) 237\u2013270 (CRC, Boca Raton, 2007)."},{"key":"BFnrd2742_CR70","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413\u20137417 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR71","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","volume":"86","author":"RW Malone","year":"1989","unstructured":"Malone, R. W., Felgner, P. L. & Verma, I. M. Cationic liposome-mediated RNA transfection. Proc. Natl Acad. Sci. USA 86, 6077\u20136081 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR72","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1086\/504267","volume":"193","author":"TW Geisbert","year":"2006","unstructured":"Geisbert, T. W. et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 193, 1650\u20131657 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFnrd2742_CR73","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1371\/journal.pmed.0030096","volume":"3","author":"P Kumar","year":"2006","unstructured":"Kumar, P., Lee, S. K., Shankar, P. & Manjunath, N. A single siRNA suppresses fatal encephalitis induced by two different Flaviviruses. PLoS Med. 3, e96 (2006).","journal-title":"PLoS Med."},{"key":"BFnrd2742_CR74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","volume":"24","author":"W Li","year":"2007","unstructured":"Li, W. & Szoka, F. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24, 438\u2013449 (2007).","journal-title":"Pharm. Res."},{"key":"BFnrd2742_CR75","doi-asserted-by":"publisher","first-page":"11454","DOI":"10.1073\/pnas.93.21.11454","volume":"93","author":"CJ Wheeler","year":"1996","unstructured":"Wheeler, C. J. et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl Acad. Sci. USA 93, 11454\u201311459 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"H Lv","year":"2006","unstructured":"Lv, H., Zhang, S., Wang, B., Cui, S. & Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114, 100\u2013109 (2006).","journal-title":"J. Control. Release"},{"key":"BFnrd2742_CR77","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bbrc.2005.03.041","volume":"330","author":"Z Ma","year":"2005","unstructured":"Ma, Z. et al. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 330, 755\u2013759 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrd2742_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.addr.2007.03.010","volume":"59","author":"S Akhtar","year":"2007","unstructured":"Akhtar, S. & Benter, I. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Adv. Drug Deliv. Rev. 59, 164\u2013182 (2007).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrd2742_CR79","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1172\/JCI33494","volume":"117","author":"S Akhtar","year":"2007","unstructured":"Akhtar, S. & Benter, I. F. Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 117, 3623\u20133632 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrd2742_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10611860601151860","volume":"15","author":"AJ Hollins","year":"2007","unstructured":"Hollins, A. J., Omidi, Y., Benter, I. F. & Akhtar, S. Toxicogenomics of drug delivery systems: exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J. Drug Target. 15, 83\u201388 (2007).","journal-title":"J. Drug Target."},{"key":"BFnrd2742_CR81","first-page":"35","volume":"25","author":"DM Rust","year":"1998","unstructured":"Rust, D. M. & Jameson, G. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice. Oncol. Nurs. Forum 25, 35\u201348 (1998).","journal-title":"Oncol. Nurs. Forum"},{"key":"BFnrd2742_CR82","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature06179","volume":"449","author":"M John","year":"2007","unstructured":"John, M. et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449, 745\u2013747 (2007). Demonstration that specific, non-viral RNAi delivery can be achieved without interruption of endogenous microRNA processing.","journal-title":"Nature"},{"key":"BFnrd2742_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.chom.2008.04.003","volume":"3","author":"S Epiphanio","year":"2008","unstructured":"Epiphanio, S. et al. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine Plasmodium liver infection. Cell Host Microbe 3, 331\u2013338 (2008).","journal-title":"Cell Host Microbe"},{"key":"BFnrd2742_CR84","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92, 7297\u20137301 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR85","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nmat1645","volume":"5","author":"D Putnam","year":"2006","unstructured":"Putnam, D. Polymers for gene delivery across length scales. Nature Mater. 5, 439\u2013451 (2006).","journal-title":"Nature Mater."},{"key":"BFnrd2742_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jgm.696","volume":"7","author":"A Akinc","year":"2005","unstructured":"Akinc, A., Thomas, M., Klibanov, A. M. & Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657\u2013663 (2005).","journal-title":"J. Gene Med."},{"key":"BFnrd2742_CR87","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1016\/j.biomaterials.2006.05.049","volume":"27","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Chen, P. & Shen, J. The development and characterization of a glutathione-sensitive cross-linked polyethylenimine gene vector. Biomaterials 27, 5292\u20135298 (2006).","journal-title":"Biomaterials"},{"key":"BFnrd2742_CR88","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejpb.2004.11.011","volume":"60","author":"U Lungwitz","year":"2005","unstructured":"Lungwitz, U., Breunig, M., Blunk, T. & G\u00f6pferich, A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60, 247\u2013266 (2005).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"BFnrd2742_CR89","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1021\/bc800065f","volume":"19","author":"A Zintchenko","year":"2008","unstructured":"Zintchenko, A., Philipp, A., Dehshahri, A. & Wagner, E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug. Chem. 19, 1448\u20131455 (2008).","journal-title":"Bioconjug. Chem."},{"key":"BFnrd2742_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.gt.3302376","volume":"12","author":"PH Tan","year":"2004","unstructured":"Tan, P. H., Yang, L. C., Shih, H. C., Lan, K. C. & Cheng, J. T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12, 59\u201366 (2004).","journal-title":"Gene Ther."},{"key":"BFnrd2742_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.gt.3302425","volume":"12","author":"B Urban-Klein","year":"2004","unstructured":"Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F. & Aigner, A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12, 461\u2013466 (2004).","journal-title":"Gene Ther."},{"key":"BFnrd2742_CR92","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/jgm.507","volume":"6","author":"A Kichler","year":"2004","unstructured":"Kichler, A. Gene transfer with modified polyethylenimines. J. Gene Med. 6, S3\u2013S10 (2004).","journal-title":"J. Gene Med."},{"key":"BFnrd2742_CR93","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0169-409X(01)00202-2","volume":"53","author":"R Kircheis","year":"2001","unstructured":"Kircheis, R., Wightman, L. & Wagner, E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 53, 341\u2013358 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrd2742_CR94","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1007\/s11095-006-9009-2","volume":"23","author":"A Richards Grayson","year":"2006","unstructured":"Richards Grayson, A., Doody, A. & Putnam, D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 23, 1868\u20131876 (2006).","journal-title":"Pharm. Res."},{"key":"BFnrd2742_CR95","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1073\/pnas.0502067102","volume":"102","author":"M Thomas","year":"2005","unstructured":"Thomas, M. et al. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl Acad. Sci. USA 102, 5679\u20135684 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2006.02.009","volume":"112","author":"S Werth","year":"2006","unstructured":"Werth, S. et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Control. Release 112, 257\u2013270 (2006).","journal-title":"J. Control. Release"},{"key":"BFnrd2742_CR97","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1158\/0008-5472.CAN-05-0565","volume":"65","author":"S Hu-Lieskovan","year":"2005","unstructured":"Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E. & Triche, T. J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65, 8984\u20138992 (2005).","journal-title":"Cancer Res."},{"key":"BFnrd2742_CR98","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1073\/pnas.0701458104","volume":"104","author":"JD Heidel","year":"2007","unstructured":"Heidel, J. D. et al. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl Acad. Sci. USA 104, 5715\u20135721 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR99","doi-asserted-by":"publisher","first-page":"15549","DOI":"10.1073\/pnas.0707461104","volume":"104","author":"DW Bartlett","year":"2007","unstructured":"Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A. & Davis, M. E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl Acad. Sci. USA 104, 15549\u201315554 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR100","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/bit.21668","volume":"99","author":"DW Bartlett","year":"2008","unstructured":"Bartlett, D. W. & Davis, M. E. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng. 99, 975\u2013985 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"BFnrd2742_CR101","doi-asserted-by":"publisher","first-page":"12982","DOI":"10.1073\/pnas.0703778104","volume":"104","author":"DB Rozema","year":"2007","unstructured":"Rozema, D. B. et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl Acad. Sci. USA 104, 12982\u201312987 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2742_CR102","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06765","volume":"452","author":"ME Kleinman","year":"2008","unstructured":"Kleinman, M. E. et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591\u2013597 (2008). Demonstration that the anti-angiogenic effects seen upon siRNA delivery to the eye can be nonspecific and caused by TLR3 immune activation.","journal-title":"Nature"},{"key":"BFnrd2742_CR103","unstructured":"Alnylam Pharmaceuticals. Alnylam Achieves First Human Proof of Concept for an RNAi Therapeutic with GEMINI study. Alnylam Pharmaceuticals web site [online] (2008)."},{"key":"BFnrd2742_CR104","doi-asserted-by":"crossref","unstructured":"Robbins, M. et al. Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Hum. Gene Ther. 19 Aug 2008 (doi 10.1089\/hgt.2008.131).","DOI":"10.1089\/hum.2008.131"},{"key":"BFnrd2742_CR105","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ymthe.2006.04.001","volume":"14","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y. et al. Engineering mucosal RNA interference in vivo. Mol. Ther. 14, 336\u2013342 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrd2742_CR106","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.hjh.0000254374.73241.ab","volume":"25","author":"A-S Arnold","year":"2007","unstructured":"Arnold, A.-S. et al. Specific \u03b21-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia. J. Hypertens. 25, 197\u2013205 (2007).","journal-title":"J. Hypertens."}],"updated-by":[{"DOI":"10.1038\/nrd3182","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000}},{"DOI":"10.1038\/nrd2919-c1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000}}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrd2742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd2742","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd2742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:54:01Z","timestamp":1744286041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd2742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFnrd2742"],"URL":"https:\/\/doi.org\/10.1038\/nrd2742","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/nrd2919-c1","asserted-by":"object"},{"id-type":"doi","id":"10.1038\/nrd3182","asserted-by":"object"}]},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}